Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Amedeo Minichino
Person

Amedeo Minichino

Tracked across 1 events · 6 articles · First seen May 21, 2026 · Last active May 22, 2026

Sentiment
30
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 30
Tech
Baszucki Group Funds Oxford Psychosis Trial
Impact: Amedeo Minichino>>> is the study lead at the University of Oxford for the trial on ketogenic therapy for early psychosis, expressing hope that the intervention can change the long-term trajectory of mental well-being.
May 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Amedeo Minichino live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.